Cintac Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Cintac heeft een totaal eigen vermogen van $104.6M en een totale schuld van $236.3M, wat de schuld-eigenvermogensverhouding op 226% brengt. De totale activa en totale passiva bedragen respectievelijk $573.7M en $469.2M.

Belangrijke informatie

226.0%

Verhouding schuld/eigen vermogen

US$236.29m

Schuld

Rente dekkingsratio	n/a
Contant	US$17.87m
Aandelen	US$104.58m
Totaal verplichtingen	US$469.16m
Totaal activa	US$573.73m

Recente financiële gezondheidsupdates

Recent updates

Is Cintac (SNSE:CINTAC) Using Debt Sensibly?

Jan 12

Does Cintac (SNSE:CINTAC) Have A Healthy Balance Sheet?

Feb 18

Is Cintac (SNSE:CINTAC) A Risky Investment?

Apr 10

Investors Will Want Cintac's (SNSE:CINTAC) Growth In ROCE To Persist

Oct 07

We Think Cintac (SNSE:CINTAC) Can Stay On Top Of Its Debt

Apr 29

Returns On Capital Are Showing Encouraging Signs At Cintac (SNSE:CINTAC)

Apr 07

Can Cintac S.A.'s (SNSE:CINTAC) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Mar 17

Shareholders of Cintac (SNSE:CINTAC) Must Be Delighted With Their 399% Total Return

Feb 10

Cintac (SNSE:CINTAC) Has A Somewhat Strained Balance Sheet

Jan 22

Returns On Capital At Cintac (SNSE:CINTAC) Paint An Interesting Picture

Jan 04

Cintac S.A.'s (SNSE:CINTAC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Dec 17

Here's Why Cintac's (SNSE:CINTAC) Statutory Earnings Are Arguably Too Conservative

Nov 27

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $249.8M ) CINTAC } overtreffen de korte termijn passiva ( $241.4M ).

Langlopende schulden: De kortetermijnactiva CINTAC ( $249.8M ) overtreffen de langetermijnschulden ( $227.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 208.9% ) CINTAC wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van CINTAC is de afgelopen 5 jaar gestegen van 26.3% naar 226%.

Schuldendekking: De operationele kasstroom van CINTAC is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van CINTAC op haar schulden goed worden gedekt door EBIT.

Cintac Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Cintac (SNSE:CINTAC) Using Debt Sensibly?

Does Cintac (SNSE:CINTAC) Have A Healthy Balance Sheet?

Is Cintac (SNSE:CINTAC) A Risky Investment?

We Think Cintac (SNSE:CINTAC) Can Stay On Top Of Its Debt

Cintac (SNSE:CINTAC) Has A Somewhat Strained Balance Sheet

Recent updates

Third quarter 2024 earnings released: US$0.008 loss per share (vs US$0.026 loss in 3Q 2023)

New major risk - Shareholder dilution

Second quarter 2024 earnings released: US$0.025 loss per share (vs US$0.009 loss in 2Q 2023)

First quarter 2024 earnings released: US$20.24 loss per share (vs US$0.016 loss in 1Q 2023)

New major risk - Financial position

Full year 2023 earnings released: US$0.087 loss per share (vs US$0.10 loss in FY 2022)

Is Cintac (SNSE:CINTAC) Using Debt Sensibly?

Third quarter 2023 earnings released: US$0.026 loss per share (vs US$0.017 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.009 loss per share (vs US$0.003 profit in 2Q 2022)

Full year 2022 earnings released: US$0.10 loss per share (vs US$0.10 profit in FY 2021)

Does Cintac (SNSE:CINTAC) Have A Healthy Balance Sheet?

Less than half of directors are independent

Third quarter 2022 earnings released: US$0.017 loss per share (vs US$0.031 profit in 3Q 2021)

Second quarter 2022 earnings released

First quarter 2022 earnings released: EPS: US$0.001 (vs US$0.033 in 1Q 2021)

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Upcoming dividend of US$0.051 per share

Is Cintac (SNSE:CINTAC) A Risky Investment?

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS US$0.031 (vs US$0.008 in 3Q 2020)

Investors Will Want Cintac's (SNSE:CINTAC) Growth In ROCE To Persist

Second quarter 2021 earnings released

First quarter 2021 earnings released: EPS US$0.033 (vs US$0.003 in 1Q 2020)

We Think Cintac (SNSE:CINTAC) Can Stay On Top Of Its Debt

Upcoming dividend of US$0.014 per share

Returns On Capital Are Showing Encouraging Signs At Cintac (SNSE:CINTAC)

Can Cintac S.A.'s (SNSE:CINTAC) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

New 90-day high: CL$390

Shareholders of Cintac (SNSE:CINTAC) Must Be Delighted With Their 399% Total Return

Full year 2020 earnings released: EPS US$0.028 (vs US$0.007 in FY 2019)

Cintac (SNSE:CINTAC) Has A Somewhat Strained Balance Sheet

New 90-day high: CL$363

Returns On Capital At Cintac (SNSE:CINTAC) Paint An Interesting Picture

Cintac S.A.'s (SNSE:CINTAC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Here's Why Cintac's (SNSE:CINTAC) Statutory Earnings Are Arguably Too Conservative

Third quarter 2020 earnings released: EPS US$0.008

New 90-day low: CL$330

New 90-day high - CL$350

First half earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven